Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.

O'Shea, Matthew K and Tanner, Rachel and Müller, Julius and Harris, Stephanie A and Wright, Danny and Stockdale, Lisa and Stylianou, Elena and Satti, Iman and Smith, Steven G and Dunbar, James and Fletcher, Thomas E and Dedicoat, Martin and Cunningham, Adam F and McShane, Helen (2018) Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection. Scientific reports, 8 (1). p. 14480. ISSN 2045-2322.

[img]
Preview
Text
41598_2018_Article_32755.pdf

Download (3MB) | Preview
Official URL: https://www.nature.com/articles/s41598-018-32755-x

Abstract

A major contribution to the burden of Tuberculosis (TB) comes from latent Mycobacterium tuberculosis infections (LTBI) becoming clinically active. TB and LTBI probably exist as a spectrum and currently there are no correlates available to identify individuals with LTBI most at risk of developing active disease. We set out to identify immune parameters associated with ex vivo mycobacterial growth control among individuals with active TB disease or LTBI to define the spectrum of TB infection. We used a whole blood mycobacterial growth inhibition assay to generate a functional profile of growth control among individuals with TB, LTBI or uninfected controls. We subsequently used a multi-platform approach to identify an immune signature associated with this profile. We show, for the first time, that patients with active disease had the greatest control of mycobacterial growth, whilst there was a continuum of responses among latently infected patients, likely related to the degree of immune activation in response to bacillary load. Control correlated with multiple factors including inflammatory monocytes, activated and atypical memory B cells, IgG1 responses to TB-specific antigens and serum cytokines/chemokines. Our findings offer a method to stratify subclinical TB infections and the future potential to identify individuals most at risk of progressing to active disease and benefit from chemoprophylaxis.

Item Type: Article
Subjects: WC Communicabable diseases
WC Communicabable diseases > WC680 Tropical medicine
WD Diseases and disorders of systemic, metabolic or environmental origin > WD350 Immunologic diseases
Divisions: Clinical Support > Infectious Diseases
Related URLs:
Depositing User: Mr Philip O'Reilly
Date Deposited: 28 Oct 2019 10:52
Last Modified: 28 Oct 2019 10:52
URI: http://www.repository.uhblibrary.co.uk/id/eprint/2530

Actions (login required)

View Item View Item